TrialAnnals of hematology2023

Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA.

Kenshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.